Modelling the evolution of drug resistance in the presence of antiviral drugs

January 2007
BMC Public Health;2007, Vol. 7 Issue 1, p300
Academic Journal
No abstract available.


Related Articles

  • A phylogenetic and Markov model approach for the reconstruction of mutational pathways of drug resistance. Buendia, Patricia; Cadwallader, Brice; DeGruttola, Victor // Bioinformatics;Oct2009, Vol. 25 Issue 19, p2522 

    Motivation: Modern HIV-1, hepatitis B virus and hepatitis C virus antiviral therapies have been successful at keeping viruses suppressed for prolonged periods of time, but therapy failures attributable to the emergence of drug resistant mutations continue to be a distressing reminder that no...

  • Antiviral drug resistance. Pillay, Deenan; Geddes, Alisdair M. // BMJ: British Medical Journal (International Edition);8/31/96, Vol. 313 Issue 7056, p503 

    Discusses various aspects of antiviral drug resistance. Drug resistant infections; Transmission of resistant viruses; Clinical and public health implications.

  • Can treatment increase the epidemic size? Xiao, Yanyu; Brauer, Fred; Moghadas, Seyed // Journal of Mathematical Biology;Jan2016, Vol. 72 Issue 1/2, p343 

    Antiviral treatment is one of the key pharmacological interventions against many infectious diseases. This is particularly important in the absence of preventive measures such as vaccination. However, the evolution of drug-resistance in treated patients and its subsequent spread to the...

  • Potential Benefits of Sequential Inhibitor-Mutagen Treatments of RNA Virus Infections. Perales, Celia; Agudo, Rubén; Tejero, Hector; Manrubia, Susanna C.; Domingo, Esteban // PLoS Pathogens;Nov2009, Vol. 5 Issue 11, p1 

    Lethal mutagenesis is an antiviral strategy consisting of virus extinction associated with enhanced mutagenesis. The use of non-mutagenic antiviral inhibitors has faced the problem of selection of inhibitor-resistant virus mutants. Quasispecies dynamics predicts, and clinical results have...

  • A review on fate of antiviral drugs in environment and detection techniques. Swati, Jain; Raj K., Vyas; Prabhat, Pandit; Sangeeta, Vyas // International Journal of Environmental Sciences;Jul2011, Vol. 1 Issue 7, p1526 

    Use of Antiviral drugs has increased during past decade to treat viral diseases. This has resulted in development of resistance of the drug towards the target virus. Antiviral drugs have emerged as a new challenge for medical fraternity and environment in general and researchers in particular....

  • Excessive Use Could Aid Deadly Flu.  // USA Today Magazine;Oct2009, Vol. 138 Issue 2773, p7 

    The article warns against the excessive use of Tamiflu, a cheap and popular antiviral agent against avian flu infection which are being stockpiled by governments in the belief it is the next drug that can combat the flu virus. It cites a study which showed that widespread use of antiviral drugs...

  • HIV wages war on 'miracle' drugs. Cohen, Philip // New Scientist;8/17/2002, Vol. 175 Issue 2356, p22 

    Reports the need to develop drugs to combat resistance to HIV virus in the U.S. Details on the screening of HIV patients for resistance; Efficacy of antiviral drugs against AIDS; Side effects of antiviral agents.

  • Predicting the emergence of drug-resistant HSV-2: new predictions. Gershengorn, Hayley B.; Darby, Graham; Blower, Sally M. // BMC Infectious Diseases;2003, Vol. 3 Issue 1, p1 

    Background: Mathematical models can be used to predict the emergence and transmission of antiviral resistance. Previously it has been predicted that high usage of antivirals (in immunocompetent populations) to treat Herpes Simplex Virus type 2 (HSV-2) would only lead to fairly low levels of...

  • Methods for optimizing antiviral combination therapies. N. Beerenwinkel; T. Lengauer; M. Däumer; R. Kaiser; H. Walter; K. Korn; D. Hoffmann; J. Selbig // Bioinformatics;Jan2009 Supplement, Vol. 19, p16 

    Motivation: Despite some progress with antiretroviral combination therapies, therapeutic success in the management of HIV-infected patients is limited. The evolution of drug-resistant genetic variants in response to therapy plays a key role in treatment failure and finding a new potent drug...

  • Mathematical modeling of multi-drugs therapy: a challenge for determining the optimal combinations of antiviral drugs. Yoshiki Koizumi; Shingo Iwami // Theoretical Biology & Medical Modelling;2014, Vol. 11 Issue 1, p41 

    In the current era of antiviral drug therapy, combining multiple drugs is a primary approach for improving antiviral effects, reducing the doses of individual drugs, relieving the side effects of strong antiviral drugs, and preventing the emergence of drug-resistant viruses. Although a variety...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics